A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice

Area of Science:

• Genetics and Molecular Biology
• Dermatology
• Immunology

Background:

• A novel spontaneous mutation leading to chronic proliferative dermatitis has been identified in C57BL/Ka mice.
• This condition presents as a skin disease with characteristic lesions and inflammatory cell infiltration.

Purpose of the Study:

• To characterize the genetic basis and pathological features of this new dermatitis mutation.
• To investigate the cellular and molecular mechanisms underlying the disease.
• To evaluate the efficacy of potential therapeutic interventions.

Main Methods:

• Breeding studies to determine the mode of inheritance.
• Histopathological examination of affected tissues (skin, mouth, esophagus, forestomach, liver, lung, joints).
• Immunohistochemical analysis using markers such as Mac-1, CD3, and intracellular adhesion molecule-1.
• Cell proliferation studies using bromodeoxyuridine.
• Transplantation experiments (bone marrow and spleen).
• Pharmacological treatment with triamcinolone and cyclosporin A.

Main Results:

• The disease follows an autosomal recessive inheritance pattern.
• Lesions characterized by epidermal hyperplasia, hyperkeratosis, parakeratosis, and inflammatory cell infiltration (granulocytes, macrophages, mast cells) were observed in the skin and other stratified squamous epithelia.
• Increased epithelial cell proliferation and expression of Mac-1 and intracellular adhesion molecule-1 were noted.
• The disease was not transferable via bone marrow or spleen transplants.
• Triamcinolone treatment led to lesion regression, while cyclosporin A was ineffective.

Conclusions:

• Chronic proliferative dermatitis in these mice is a genetically determined condition with distinct pathological features.
• The disease involves significant epithelial and inflammatory cell responses.
• Corticosteroids show therapeutic potential, suggesting an inflammatory component amenable to such treatment.